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β2-integrins are essential for immune system function because they mediate immune
cell adhesion and signaling. Consequently, a loss of β2-integrin expression or function
causes the immunodeficiency disorders, Leukocyte Adhesion Deficiency (LAD) type I and
III. LAD-III is caused by mutations in an important integrin regulator, kindlin-3, but exactly
how kindlin-3 regulates leukocyte adhesion has remained incompletely understood.
Here we demonstrate that mutation of the kindlin-3 binding site in the β2-integrin
(TTT/AAA-β2-integrin knock-in mouse/KI) abolishes activation of the actin-regulated
myocardin related transcription factor A/serum response factor (MRTF-A/SRF) signaling
pathway in dendritic cells and MRTF-A/SRF-dependent gene expression. We show that
Ras homolog gene family, member A (RhoA) activation and filamentous-actin (F-actin)
polymerization is abolished in murine TTT/AAA-β2-integrin KI dendritic cells, which leads
to a failure of MRTF-A to localize to the cell nucleus to coactivate genes together with SRF.
In addition, we show that dendritic cell gene expression, adhesion and integrin-mediated
traction forces on ligand coated surfaces is dependent on the MRTF-A/SRF signaling
pathway. The participation of β2-integrin and kindlin-3-mediated cell adhesion in the
regulation of the ubiquitous MRTF-A/SRF signaling pathway in immune cells may help
explain the role of β2-integrin and kindlin-3 in integrin-mediated gene regulation and
immune system function.
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INTRODUCTION
Leukocyte adhesion is an essential process in immunity. Adhesion is necessary for leukocyte
surveillance in tissues, phagocytosis, lymphocyte homing, leukocyte extravasation, T-cell priming,
and cytotoxic killing. One of the most important group of adhesion molecules on leukocytes are
the β2-integrins. β2-integrins are transmembrane proteins consisting of the β-chain CD18 which
forms heterodimers with the four α-chains: CD11a, CD11b, CD11c, and CD11d, forming 4 different
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receptors e.g., CD11a/CD18 (LFA-1, αLβ2, ITAL Ag),
CD11b/CD18 (Mac-1, αMβ2, CR3, ITAM Ag), CD11c/CD18
(p150p95, αXβ2, CR4, ITAX Ag), CD11d/CD18 (αDβ2, ITAD
Ag) (1).
β2-integrins participate in the leukocyte adhesion cascade
where they mediate slow rolling and firm adhesion to the
endothelium (2). During this process β2-integrins bind
intercellular adhesion molecules (ICAMs) expressed on
endothelial cells. In addition to ICAMs, β2-integrins also bind to
a vast variety of other ligands such as complement protein iC3b
during phagocytosis (3).
Integrins have been found to transmit signals bidirectionally,
which means that they mediate inside-out and outside-in
signaling during cell adhesion. On resting leukocytes integrins
are typically in an inactive, bent conformation which prevents
ligand binding (2). Intracellular signaling initiated for example by
chemokine receptors eventually leads to integrin conformational
changes into an active conformation that has an increased affinity
for ligands (inside-out signaling) (4). Subsequent integrin-
ligand binding results in further recruitment of integrins and
cytoskeletal proteins to the adhesion site, followed by integrin-
mediated outside-in signaling leading to further cellular changes.
Integrin conformational changes are regulated by binding of
cytoplasmic cofactors to the cytoplasmic tail of the β2-integrin
(5). The best characterized integrin cofactor is talin, which is
associated with the active (high affinity) integrin conformation
and mediates further binding of cytoplasmic proteins such as
actin and focal adhesion kinase (6). Talin has been shown to
mediate integrin downstream signaling under higher forces. Low
and intermediate force transmission is mediated by another
cytoplasmic integrin cofactor, kindlin (6).
The importance of adhesion molecules, their ligands and their
cytoplasmic interaction partners is demonstrated in a group
of immunodeficiencies termed leukocyte adhesion deficiencies
(LAD). While LAD-I is caused by reduced or abolished
expression of β2-integrins (7), LAD-III is caused by the mutation
or absence of kindlin-3. LAD patients experience recurrent
bacterial and fungal infections as well as severe bleeding (in LAD-
III only) as a result of impaired leukocyte and platelet adhesion.
Kindlin-3-null mice have a similar phenotype as LAD-
III patients, demonstrating the importance of kindlin-3 in
integrin regulation (8). While it has been demonstrated that
only a low level of kindlin-3 is required to enable proper β2-
integrin function (9), the exact mechanism by which kindlin-3
regulates adhesion remains incompletely characterized (10). We
have previously established a mouse model with a TTT/AAA
β2-integrin knock-in mutation, which results in kindlin-3
being unable to bind to β2-integrins and consequently a loss
of leukocyte adhesion (11). Furthermore, the reduced β2-
integrin/kindlin-3 interaction leads to a range of phenotypic
changes in leukocytes (11–13). Interestingly, TTT/AAA-β2-
integrin KI dendritic cells (DCs) display an increased maturation
phenotype. They express higher level of costimulatory markers
such as CD40, CD80, CD86, chemokine receptors (CCR7) and
produce more cytokines (IL-12, IL-10) than wild type cells.
KI dendritic cells also display increased migration to lymph
nodes and induce increased Th1 responses in vivo compared to
WT dendritic cells (12). While these experiments indicate that
active β2-integrins suppress the mature, migratory dendritic cell
phenotype, the signaling pathways downstream of β2-integrins
that mediate this phenotypic switch have not been identified.
SRF has been termed the master regulator of the cytoskeleton
as this transcription factor regulates the expression of many
cytoskeletal genes. The majority of SRF-mediated transcription
of cytoskeletal genes has been shown to be dependent on
its cofactor MRTF-A. In leukocytes, MRTF-A/SRF have been
shown to regulate the expression of cytoskeletal proteins as
well as β2-integrins (14–16). The MRTF-A/SRF pathway is
activated in response to external cell stimuli which initiates F-
actin polymerization downstream of RhoA activation. MRTF-
A constantly shuttles between the cytoplasm and the nucleus
but has been shown to be mainly cytoplasmic in resting cells.
In the cytoplasm MRTF-A is bound to G-actin, thus upon F-
actin polymerization MRTF-A is released and free to shuttle into
the nucleus. Nuclear MRTF-A then initiates gene transcription
together with SRF (17).
Here we show that kindlin-3-regulated β2-integrin adhesion
is required for signaling via RhoA and actin to initiate MRTF-
A nuclear localization in dendritic cells. Furthermore, dendritic
cell adhesion, traction force generation and gene expression
is regulated by MRTF-A/SRF signaling. These results may
help explain the role of β2-integrins and kindlin-3 in gene




Bone marrow was collected from euthanized male and female
C57Bi/6NCrl (Charles River), previously described TTT/AAA
β2-integrin knock-in mice (11) (8–39 weeks) and full MRTF-
A knockout and control mice previously described in Cheng
et al. (18). Fetal liver cells were collected from Kindlin-3−/− and
control mice. Experiments were performed according to Finnish
Act on Animal Experimentation (62/2006) and approved by the
Finnish National Animal Experiment Board. Kindlin-3−/− and
control mice were handled in strict accordance with regulations
in Germany regarding the use of laboratory animals.
Dendritic Cell Culture
Dendritic cells were generated by culturing bone marrow for 9–
10 days (media change on day 3; 6 and 8) in 10 ng/ml GM-CSF
(Peprotech) RPMI+10% FCS, 100 U/ml Pen/Strep and 2mM L-
glutamine. In some experiments, 10µMCCG1423 (Cayman) was
used to inhibit MRTF-A for 2 days before experiments.
Immunohistochemistry
1x106 dendritic cells on uncoated, iC3b (6µg/ml; Calbiochem)
or fibronectin (10µg/ml; Calbiochem) coated coverslips were
serum starved for 1 h with 0.3% FCS/RPMI, followed by
serum stimulation (15% FCS 30min). In adhesion stimulation
experiment WT and KI dendritic cells were detached, serum
starved in suspension for 1h and stimulated with replating the
cells on glass coverslips or on iC3b coated coverslips for 1h. Cells
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were fixed with 4% PFA. F-actin content of 25–100 cells/animal
was assessed via measurement of corrected total cell fluorescence
(CTCF) of TRITC-phalloidin (Sigma) as described in Abashidze
et al. (19). All slides were imaged using a Leica SP5 II (Leica
Microsystems) LAS AF Lite Software, with 561 Laser (10% laser
power). Z-stacks were taken with the following parameters:
Spectral Range: 570–779 nm, QD405/488/561/635 mirror, Smart
Gain 800V, Smart Offset 0,0%, Pinhole 111.49µm, Zoom: 1,00;
Objective 63X, z-Distance 8.003µm, 55 steps, Format 512× 512.
MRTF-A staining was performed on non-starved, serum
starved, and serum stimulated cells. After fixation cells were
permeabilized with 0,2% Triton-x/PBS for 5min and stained
for 1 h with anti MRTF-A (C-19, sc-21558, Santa Cruz
Biotechnology) 1:100 in 1%FBS/PBS.
RhoA Bound GTP Level
The RhoA activity was assessed via RhoA G-LISA Activation
Assay Kit (Cytoskeleton Inc, Denver) according to the
manufacturer’s instructions. Samples were collected from
serum starved cells to acquire a non-stimulated baseline level of
GTP-bound RhoA (determined for each biological repeat and set
to 1). Based on this value the fold change of RhoA activation was
calculated for serum-stimulated cells (serum starvation followed
by 15% FCS for 10min). All samples were collected on ice and
snap frozen in liquid nitrogen within 10min after lysing the cells
and stored at−80◦C until G-LISA was run.
Static Adhesion Assay
Static adhesion assay with resting and activated (200 nM PdBu,
Sigma-Aldrich) cells at 0,2 x 106 cells/ml on ICAM-1 (6 µg/ml;
R&D Systems) and iC3b (6µg/ml; Calbiochem) was performed
as previously described (20). Rescue experiments with MRTF-A
were performed after cell transfection as follows: CD11b, CD18
WT, CD18 TTT/AAA, MRTF-A∗∗∗(21) in pCDNA3.1 vector or
a combination of them were transfected into COS-1 cells using
Xfect (Takara) following the manufacturer’s guidelines. After
transfection, the cells were incubated for 48 h at 37◦C before
static adhesion and western blot experiments.
Western Blot
Transfected cells were lysed in M-PER lysis buffer (Thermo
Scientific) in the presence of phosphatase and protease inhibitors
(Pierce), and lysates were analyzed by Western blotting. Primary
antibodies against MRTF-A, and against myc-tag were from
Santa Cruz.
Flow Cytometry
Following Fc block (eBiosciences, 93) cells were stained with the
following antibodies: CD11a-PE (BioLegend, 2D7), CD18-FITC
(BD Biosciences, C71/16) CD11c-PE-Cy7 (eBioscience, N418),
CD11b-APC (BioLegend, M1/70), CD80-APC (eBioscience, 16-
10A1), CCR7-PE (BioLegend, 4B12), CD40-PE (BioLegend,
3/23), CD86-FITC (BD Biosciences, GL1). FITC-conjugated
antibodies were used at 1:100 dilution, all other antibodies were
used at 1:200 dilution. Data were acquired using a LSRForetessa
(BD) and analyzed using FlowJo software (TreeStar, USA).
Traction Force Microscopy
200.000 dendritic cells in 2ml whole media were incubated for 3h
on iC3b (6µg/ml in PBS Calbiochem) -coated silicone-based gel
substrates (Young’s Modulus= 1 kPa)(Matrigen, USA).
For MRTF-A−/− and control experiments, cells were
plated on elastic polyacrylamide (PAA) gel substrates (Young’s
Modulus = 1 kPa) (22). Substrates were covered with
sulfate fluorescent microspheres (Invitrogen, diameter 200 nm;
excitation wavelength 488) before coating with iC3b. Sulfo-
SANPAH (Sigma-Aldrich) was used as a linker in between the
substrate and the coating. Cells were incubated on substrates for
1h prior to imaging. Single cells together with the underlying
beads were imaged with 3I Marianas imaging system (3I
intelligent Imaging Innovations, Germany) at +37◦C in 5%
CO2. A 63x/1.2W C-Apochromat CorrWD=0.28 M27 objective
was used. Following live cell imaging, cells were detached from
the gel substrates with 10 × Trypsin (Lonza) and a second
set of nanobead images, serving as reference images, were
obtained. Spatial maps of cell-exerted nanobead displacements
were achieved by comparing the reference bead images together
with the experimental images. With the knowledge of the bead
displacement fields, substrate stiffness (1 kPa), and a manual
trace of the cell boundary, the cell-exerted traction fields were
computed by using Fourier Transform Traction Cytometry (23,
24). The root mean squared magnitude was computed from the
traction field.
Cell Migration Assays
3D migration assays were performed with µ-Slide Chemotaxis
3D (Ibidi) imaging slides according the manufacturer’s protocol.
Briefly, dendritic cells were mixed into a 1.5 mg/ml bovine
collagen I (cellsystemsSlides) mix and injected into the slide’s
thin imaging strip. After 45min collagen polymerization, one of
two chambers flanking the imaging strip were filled with media,
and the other with media containing 1.25µg/ml mCCL19 (R&D
systems). One slide was used for each condition, assays were
repeated 3 times. Dendritic cells were imaged using 3I Marianas
imaging system (3I intelligent Imaging Innovations, Germany)
by utilizing multipoint imaging. Controls were always imaged
before treated or knock-in/-out dendritic cells. A 10x/0.30 EC
Plan-Neofluar Ph1 WD = 5.2 M27 objective was used, the dish
was placed in a heated sample chamber (+37◦C), controlled for
CO2. Cells were imaged using bright field, for 4 h every minute.
qPCR
Total RNA was isolated from WT and WT MRTF-A inhibited
dendritic cells with Nucleospin RNA kit (Macherey-Nagel)
and converted into cDNA with High-Capacity cDNA Reverse
Transcription kit (Thermo Fisher Scientific) according to
the manufacturers’ protocols. The quantitative Real-Time
PCR (qRT-PCR) was performed by using Taqman chemistry.
Briefly, the cDNA was amplified in a 11 µl volume containing
1 x TaqMan Fast Advanced Master Mix and predeveloped
TaqMan primers and probes (CCR7 Mm01301785_m1,
CD11a Mm00801807_m1). 18S rRNA (Eukaryotic 18S rRNA
Endogenous Control, Thermo Fisher Scientific) was used as a
reference gene and no template control (NTC) was included in
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each assay. Reactions were run with CFX96 Touch Real-Time
PCR Detection System (Bio-Rad) with a program consisting of
initial steps of 50◦C for 2min and 95◦C for 20 s followed by 40
cycles of 95◦C for 3 s and 60◦C for 30 s. Each sample was run in
triplicate. qRT-PCR data was analyzed by using CFX Maestro
(Bio-Rad) and finalized with Excel(Microsoft). Relative units
were calculated by using the comparative CT method which has
been described elsewhere (25).
mRNA Sequencing
The sequencing was performed at the Biomedicum Functional
Genomics Unit (FuGU) of the University of Helsinki with
the Illumina NextSeq500 using a NextSeq Mid Output 150
cycle flow cell. From 2µg of total RNA from each biological
replicate (4 MRTF-A−/− and 4 MRTF-A+/+, age matched),
Library preparation was done using a NEBNext R© UltraTM
II Directional RNA Library Prep Kit for Illumina (E7760)
and mRNA enrichment was done by NEBNext R© Poly(A)
mRNA Magnetic Isolation Module (E7490), according to
manufacturer’s protocols. 10 PCR cycles were used. Libraries’
concentrations were determined by Qubit, while quality and size
distribution were analyzed using Bioanalyzer 2100. Fastq files are
deposited at NCBI’s Gene Expression Omnibus (GEO) database
with BioProject ID PRJNA535475 and BioSample accession
number SAMN11506732.
RNA-Seq Data Analysis
The sequencing quality of raw RNA-Seq reads from fastq files was
evaluated by FastQC (http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/). Sequencing reads were then aligned against
the mouse reference genome (Mus musculus GRCm38.95)
by HISAT2 (26). Transcripts were counted using HTSeq
(27). Differential expression analysis was performed by the R
Bioconductor package DESeq2 (28) using <0.05 as cutoff for
the adjusted p-value. Heatmaps were generated from normalized
expression (regularized log transformation) values for individual
samples that were obtained from DESeq2.
Pathway Enrichment Analysis
All the differentially expressed genes having adjusted p-value
<0.05 (calculated by DESeq2) were ranked by their log2 fold-
changes. Pathway enrichment analysis for GO biological process
of the ranked gene list was done with the GSEA software
version 3.0 (29) against C5 gene ontology biological process
dataset (version 6.2) downloaded from molecular signature
database (MSigDB). The GSEA output was further processed and
visualized using EnrichmentMap (version 3.2.0) on Cytoscape
(version 3.7.1). In addition, pathway enrichment analysis for
reactome pathways was performed by g:Profiler (30).
Statistics
The Student’s 2-tailed t-test and Mann-Whitney test, were used
to calculate statistical significance in prism. For traction force
microscopy andmigration assaysMann-Whitney tests were used.
All p-values are shown as <0.05∗, <0.01∗∗, <0.005∗∗∗.
RESULTS
RhoA Activation and F-Actin
Polymerization Following Extracellular
Stimuli Are Reduced in
TTT/AAA-β2-Integrin KI Dendritic Cells
β2-integrin-mediated leukocyte adhesion to integrin ligands
requires the interaction between β2-integrin and kindlin-3 (11,
12). Reduced β2-integrin/kindlin-3 interaction in TTT/AAA-
β2-integrin KI dendritic cells leads to marked changes in gene
expression and cellular reprogramming to amigratory phenotype
(12). To identify pathways downstream of kindlin-3 that are
involved in integrin/kindlin-3-regulated gene expression in
dendritic cells, we performed Ingenuity Pathway Analysis (IPA)
of gene expression data fromWT and KI dendritic cells (12). This
software combines algorithms with published datasets of primary
literature, public and third-party databases to identify molecular
interactions, causations and model pathways. As indicated in
Table 1, the MRTF-A/SRF pathway was predicted to be inhibited
as a consequence of the reduced β2-integrin/kindlin-3 interaction
in TTT/AAA-β2-integrin KI dendritic cells.
The MRTF-A/SRF pathway is regulated by actin dynamics
in cells. G-actin-bound MRTF-A remains cytoplasmic, whilst
RhoA-induced F-actin polymerization releases this transcription
factor. MRTF-A is subsequently free to translocate into the
nucleus where it initiates transcription of cytoskeletal genes
together with SRF (17, 31, 32). Based on the IPA prediction that
the MRTF-A/SRF pathway is inhibited in KI dendritic cells, we
first set out to investigate RhoA activity and actin polymerization
in WT and KI cells. Indeed, RhoA activity in serum-stimulated
cells was lower in KI cells compared to WT cells (Figure 1A)
and in addition, serum-stimulated F-actin polymerization was
significantly decreased in KI dendritic cells compared to WT
dendritic cells (Figures 1B,C). These results show that β2-
integrins are upstream of RhoA-mediated F-actin polymerization
in dendritic cells.
MRTF-A Nuclear Shuttling Is Impaired as a
Result of Mutated CD18 or Deleted
Kindlin-3
As F-actin polymerization initiates MRTF-A nuclear shuttling,
allowing regulation of gene transcription together with SRF
(33, 34) we investigated serum-induced MRTF-A shuttling
in dendritic cells. In resting as well as serum starved
dendritic cells MRTF-A was mainly cytoplasmic independent of
functional β2-integrin/kindlin-3 interaction, as expected. Serum








SRF Transcription regulator 3,01E-10
MRTF-B/MKL2 Transcription regulator Inhibited 1,88E-09
MRTF-A/MKL1 Transcription regulator Inhibited 4,24E-09
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FIGURE 1 | Abolished β2-integrin/kindlin-3 link leads to impaired actin
dynamics and impaired nuclear MRTF-A shuttling. (A) RhoA activity in WT and
KI dendritic cells was measured in serum starved cells (0.3% fetal calf serum
(FCS)/RPMI for 1 h) and serum-stimulated cells (15% FCS for 10min). N = 3,
one representative result is shown. (B) F-actin content was assessed via
measurement of corrected total cell fluorescence (CTCF) of TRITC-phalloidin
stained cells. Baseline level of F-actin was acquired from serum starved cells
and F-actin fold change was calculated for 15% FCS-stimulated cells (30min
stimulation). 25–100 cells per condition were measured, N = 3.
(C) Immunofluorescence images of serum starved and serum-stimulated WT
and KI cells stained with TRITC-phalloidin. *p < 0.05.
stimulation led to MRTF-A translocation into the nuclei of WT
dendritic cells, however in KI dendritic cells MRTF-A remained
predominantly cytoplasmic (Figures 2A,B).
These results confirm the IPA results and suggest that RhoA
activity, actin dynamics and MRTF-A shuttling are dependent
on functional β2-integrins in dendritic cells. However, these
results do not exclude the possibility that except for kindlin-
3, also other cytoplasmic factors that bind to the TTT site
in the β2-integrin cytoplasmic tail may regulate this pathway.
Therefore, in order to further pinpoint the β2-integrin cofactor
involved in activating the MRTF-A/SRF pathway we analyzed F-
actin polymerization and MRTF-A shuttling in Kindlin-3 −/−
dendritic cells. Indeed, Kindlin-3−/− dendritic cells showed
impaired F-actin polymerization and MRTF-A shuttling similar
to KI cells (Figures 2C,D).
To examine whether integrin/kindlin complexes per se, or
integrin- and kindlin-3-regulated adhesion, is responsible for
regulating MRTF-A nuclear shuttling, we investigated whether
the β2-integrin ligand iC3b could induce MRTF-A nuclear
shuttling in DCs. Indeed, placing DCs on iC3b allowed for
MRTF-A nuclear shuttling in WT but not β2-integrin KI
DCs (Figure 2E). However, placing the β2-integrin KI cells
on fibronectin-coated surfaces, which allows for β1-integrin-
mediated adhesion of these cells, allowed for MRTF-A nuclear
shuttling both in the absence and presence of serum (Figure 2F).
These results show that integrin-mediated adhesion, rather than
integrin/kindlin signaling, is responsible for the shuttling of this
transcription factor in DCs.
These results confirm that MRTF-A nuclear shuttling is
regulated by kindlin-3 regulated, β2-integrin-mediated cell
adhesion, which in turn mediates RhoA activation, F-actin
polymerization and MRTF-A nuclear shuttling in dendritic
cells. These results further confirm the bioinformatics data
showing that β2-integrin/kindlin-3 regulates MRTF-A/SRF-
mediated gene expression in dendritic cells.
Inhibition of MRTF-A in WT Dendritic Cells
Does Not Regulate Dendritic Cell
Costimulatory Molecule Expression or Cell
Migration in 3D
We have previously shown that the β2-integrins negatively
regulate dendritic cell maturation, which is associated with
increased surface expression of CD40, CD80 and CD86
costimulatory molecules and the chemokine receptor CCR7 in
TTT/AAA-β2-integrin KI cells (12). CCR7 is the receptor for
chemokines CCL19 and CCL21 which guides dendritic cells
to the lymph nodes where they engage in T-cell priming.
In order to investigate whether the MRTF-A/SRF pathway is
involved in regulating dendritic cell maturation downstream of
β2-integrins, we inhibited MRTF-A with a specific inhibitor,
CCG1423 in WT dendritic cells and analyzed phenotypic
changes by flow cytometry (Figure 3). We did not find
significant changes in CD40, CD80, or CD86 expression in
CCG1423-treated WT dendritic cells as compared to WT non-
treated dendritic cells. MRTF-A inhibition, led to a significant
increase in CCR7 expression on the cell surface in DCs,
although mRNA levels were not affected (Figures 3D–F).
CCR7 levels were not increased in MRTF-A −/− DCs
(Figure 3E).
MRTFA/SRF has been previously linked to cell migration
in neutrophils, lymphoblasts and hematopoetic stem cells
(14, 35, 36). We therefore asked the question whether the
MRTF-A/SRF pathway regulates dendritic cell migration. We
compared dendritic cell migration speeds in a 3D collagen
matrix after MRTF-A inhibition or deletion in the presence
of chemokine CCL19 (Figures 3G,H). Surprisingly, we did not
find a significant difference between migration speed either
after MRTF-A inhibition with CCG1423 nor as a consequence
of MRTF-A deletion (utilizing MRTF-A−/−) in dendritic cells
(Figures 3G,H). In summary we have found that the MRTF-
A/SRF pathway in dendritic cells is downstream of β2-integrins
but does not regulate dendritic cell expression of costimulatory
molecules, nor cell migration in 3D.
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FIGURE 2 | Abolished β2-integrin mediated adhesion leads to impaired nuclear MRTF-A shuttling. (A) Total percentages of dendritic cells with nuclear MRTF-A and
cytoplasmic MRTF-A are shown. N = 4 and 200 cells per condition were analyzed. MRTF-A staining was performed on non-starved, starved and serum stimulated
cells and (B) immunofluorescence images of WT and KI cells are shown after serum stimulation. (C) F-actin content as CTCF of WT and kindlin-3−/− 25–100 dendritic
cells per condition were measured, N = 2. (D) Total percentages of kindlin-3−/− and WT dendritic cells with nuclear MRTF-A and cytoplasmic MRTF-A are shown. (E)
Total percentages of adhesion on iC3b induced nuclear MRTF-A and cytoplasmic MRTF-A are shown. WT and KI dendritic cells were detached, serum starved in
suspension, and stimulated with replating on glass coverslips or on iC3b coated coverslips. (F) Total percentages of WT dendritic cells starved on glass compared to
KI dendritic cells seeded overnight on fibronectin with nuclear MRTF-A and cytoplasmic MRTF-A. KI dendritic cells were serum starved and stimulated. (A–F) If not
otherwise indicated: N = 3 and 200 cells per condition were analyzed. MRTF-A staining was performed on non-starved, starved, and serum stimulated cells.
MRTF-A Regulates Gene Expression of
Cell Cycle, Lipid Metabolism, and
Cytoskeletal Genes in Dendritic Cells
Although the MRTF-A/SRF pathway is often described as
the “master regulator of the cytoskeleton,” the role of the
MRTF-A/SRF pathway in regulation of gene expression in
dendritic cells has not previously been investigated. To generate
more in-depth understanding of the role of the MRTF-A/SRF
pathway in dendritic cells, we therefore performed RNA-
Seq analysis of MRTF-A−/− cells (Supplementary Table 1,
Supplementary Figure 1). 1401 genes were found to be
differentially expressed between WT and MRTF-A−/− cells.
429 of the MRTF-A-regulated, differentially expressed genes
are also regulated by β2-integrins in DCs (12) (Figure 4A).
The main pathways affected were cell cycle-related, but also
for example lipid metabolism genes appear to be regulated by
MRTF-A. However, also cytoskeletal genes and Rho GTPase
signaling were significantly affected by MRTF-A deletion in
dendritic cells (Figures 4B,C). Several cytoskeletal genes and
cytoskeletal modulators, such as Fgr, Hck, Stmn1, Ckap2l,
Anln, Tpm2, Tubb5, are downregulated both in MRTF-A−/−
and TTT/AAA-β2-integrin KI dendritic cells (Figure 4D).
Together, these data further indicate that β2-integrin and
MRTF-A are on a common pathway regulating gene expression
in dendritic cells.
MRTF-A Inhibition Results in Decreased
Dendritic Cell Adhesion
One of the most prominent phenotypical changes of TTT/AAA-
β2-integrin KI dendritic cells is their reduced adhesion. Many
cytoskeletal proteins are necessary for cell adhesion. We
hypothesized that the reduced adhesion in KI cells may be
partly due to the suppression of the MRTF-A/SRF pathway
and subsequent changes in expression of cytoskeletal genes. We
thus analyzed static adhesion of MRTF-A inhibited dendritic
cells to β2-integrins ligands ICAM-1 and iC3b. As shown
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FIGURE 3 | Inhibition but not deletion of MRTF-A leads to altered CCR7
expression and no change in migration speed. (A) CD40 (B) CD80 (C)
CD86 and (D) CRR7 expression in WT NT and MRTF-A inhibited dendritic
cells (N = 6); (E) CCR7 expression of MRTF-A −/− and MRTF-A+/+ (N = 5);
surface marker expression was determined by flow cytometry. (F) CCR7
mRNA level of MRTF-A inhibited and NT WT dendritic cells determined by
qPCR (N = 4). (G) Scatter plots of tracked WT NT and WT MRTF-A inhibited
and (H) MRTF-A−/− and MRTF-A+/+ dendritic cell speeds in a 3D collagen
matrix toward CCL19 are shown. Only cells faster than 1 µm/min have been
evaluated as migratory and used for the analysis. * p < 0.05.
in Figures 5A,B, β2-integrin-mediated adhesion of MRTF-
A inhibited WT dendritic cells was significantly reduced,
although not as drastically as in TTT/AAA-β2-integrin KI
cells. A similar reduction in adhesion was seen in MRTF-
A−/− dendritic cells (Figure 5C). There are two MRTF
isoforms present in most cells: MRTF-A and MRTF-B (33).
RNA-Seq analysis confirmed that murine dendritic cells
express both MRTF-A and MRTF-B, with MRTF-A being
expressed at higher levels than MRTF-B (Figure 5D). The
difference in adhesion of the MRTF-A −/− dendritic cells as
compared to inhibitor-treated cells could thus be explained
by MRTF-B partly compensating for MRTF-A functions in
these cells.
To investigate whether MRTF-A-regulated gene expression by
itself could rescue adhesion in TTT/AAA-β2-integrin KI cells,
we cotransfected COS-cells with TTT/AAA-β2-integrins and a
constitutively active form of MRTF-A that can enter the nucleus
without cell stimulation (21) and investigated cell adhesion in
these cells. MRTF-A-∗∗∗ did not rescue TTT/AAA-β2-integrin-
mediated adhesion in transfected COS cells, indicating that this
pathway alone is not sufficient to drive cell adhesion when
kindlin cannot bind to the integrin to induce integrin activation
(Figures 5E,F). Nevertheless, these results show that the MRTF-
A/SRF pathways contributes to β2-integrin-mediated dendritic
cell adhesion to ligands.
β2-integrins themselves have been shown to be negatively
regulated by SRF and MRTF-A in that lack of either
transcription factor results in CD11b overexpression in
neutrophils (14, 36). In hematopoetic stem cells SRF deletion
results in integrin overexpression (35). We thus set out to
clarify if the reduced adhesive phenotype following MRTF-A
inhibition was due to downregulation of β2-integrins. We
measured surface expression levels of the β2-integrins β2-
chain (CD18) and three of the α-chains, CD11a, CD11b, and
CD11c (Figures 5G–K). Surprisingly we found that none
of these β2-integrin subunits was significantly decreased
and CD11a was even significantly increased following
MRTF-A inhibition (Figure 5G), although qPCR showed
reduced levels of expression of CD11a (Figure 5L). MRTF-
A deletion did not affect CD11a surface expression levels
(Figure 5K). Therefore, reduction of β2-integrin mediated
adhesion following MRTF-A inhibition is not due to reduced
β2-integrin expression.
The β2-Integrin/MRTFA/SRF Pathway
Contributes to Integrin-Mediated Traction
Force Generation
Integrins function as bidirectional transmitters of mechanical
forces across cell membranes. To investigate whether the
β2-integrin/kindlin-3 interaction regulates force transmission
through the integrin, we performed traction force microscopy
experiments. By comparing the beads’ positions on top
of which cells were bound to iC3b to the same bead
structure without the cell we could measure how much the
cell deforms the bead-containing hydrogel. This deformation
is due to traction forces generated during adhesion and
the force of the traction force can be calculated from
bead deformation and hydrogel substrate stiffness. Traction
force microscopy experiments comparing TTT/AAA-β2-integrin
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FIGURE 4 | Gene expression profile of MRTF-A−/− cells and comparison with integrin KI. (A) Depicted is the overlap of differently regulated genes shared by the
MRTF-A−/− vs. +/+ and the KI vs. WT RNA-Seq data. (B) Ranked list of negative logarithm of adjusted p-values from the reactome pathway enrichment analysis.
Pathway was performed using g:Profiler. (C) Node map of pathway enrichment analysis for GO biological process of the GSEA ranked gene list. Analysis is based on
RNA-Seq data derived from MRTF-A−/− and +/+ (N = 4). Nodes highlighted in red are associated with the cytoskeleton. Nodes highlighted with yellow outline
contain word “cytoskeleton.” (D) Depiction of cytoskeletal genes that are differently regulated in KI and MRTF-A−/−.
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FIGURE 5 | Inhibition of the MRTF-A/SRF pathway leads to reduced adhesion independent of β2-integrin expression. The effect of MRTF-A inhibition on dendritic cell
adhesion to (A) ICAM-1 and (B) to iC3b was compared to adhesion of TTT/AAA-β2-integrin KI cells. Adhesion of resting, non-treated (NT) WT dendritic cells was set
to 1 and fold changes for all other conditions was calculated, N = 5. (C) MRTF-A −/− dendritic cell adhesion to ICAM-1 and iC3b was compared to adhesion of
MRTF-A+/+ littermates, N = 4. (D) mRNA level of MRTF-A and MRTF-B in MRTF-A+/+ mice (N = 4) based on RNA-Seq data. (E) TTT/AAA rescue experiment with
constitutively active MRTF-A (MRTF-A***). Adhesion of non-treated COS-1 cells was set to 1 and fold change for adhesion of COS-1 cells transfected with
CD11b/CD18, CD11b/CD18-TTT/AAA (CD18 featuring the TTT/AAA mutation), and CD11b/CD18-TTT/AAA plus MRTF-A***. (F) Depiction of conditions used in
rescue experiment. (G) CD11a, (H) CD11b, (I) CD11c and (J) CD18 expression in WT NT and MRTF-A inhibited dendritic cells (N = 6). (K) CD11a expression in
MRTF-A−/− and+/+ dendritic cells (N = 5). (L) CD11a mRNA level of MRTF-A inhibited and NT WT dendritic cells determined by qPCR (N = 4). *p < 0.05, **p
< 0.01.
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KI to WT dendritic cells revealed that KI dendritic cells
generate significantly reduced traction forces on β2-integrin
ligand coated substrates compared to WT dendritic cells
(Figures 6A,B).
In order to investigate whether traction force generation was
dependent on the MRTF-A/SRF pathway downstream of β2-
integrin/kindlin-3, we performed traction force microscopy
experiments on MRTF-A inhibited WT dendritic cells.
Interestingly, MRTF-A inhibition as well as deletion resulted
in a similar decrease of integrin-mediated traction forces on
ligand coated surfaces as disruption of the β2-integrin/kindlin-3
interaction (Figures 6C–F). Together, these results show that
the β2-integrin/kindlin-3/MRTF-A/SRF pathway regulates
integrin-mediated cell adhesion as well as integrin-generated
cellular traction forces in dendritic cells.
In summary we have found that the MRTF-A/SRF pathway
in dendritic cells is downstream of β2-integrin/kindlin-3
interactions and that this pathway regulates dendritic cell gene
expression, cell adhesion and traction force generation, but not
dendritic cell migration in 3D.
DISCUSSION
Although β2-integrins are abundantly expressed in dendritic
cells, the role of β2-integrins in dendritic cell functions is
relatively poorly understood. Dendritic cell migration from
tissues to lymph nodes, which occurs in a 3D environment,
can occur without integrins (37). In addition, β2-integrins have
been shown to suppress the mature, migratory dendritic cell
phenotype (12). However, the signaling pathways downstream
of β2-integrins that mediate this phenotypic switch have not
been identified.
In this study we have identified the β2-integrin as an upstream
regulator of the MRTF-A/SRF pathway. Our results show that
β2-integrin-mediated, kindlin-3-regulated cell adhesion leads
to RhoA activation to regulate F-actin polymerization and
MRTF-A nuclear shuttling. This allows MRTF-A to coactivate
genes together with SRF. Although MRTF-A has previously
been implicated as a main player in regulating cytoskeletal
genes in other cell types, we show here by RNA-Seq analysis
that MRTF-A also regulates gene expression related to cell
cycle, lipid metabolism, and many other pathways in dendritic
cells. In macrophages, MRTF-A/SRF mediate cytoskeletal gene
expression (14, 36, 38), whilst in B cells SRF deletion led
to decreased level of IgM, CD19, and CXCR4 expression
(39). Thus our results confirm the involvement of MRTF-
A/SRF in the regulation of gene expression in immune cells,
however the effect on gene expression appears highly cell-
type specific.
We show that MRTF-A inhibition or deletion significantly
decreases adhesion to β2-integrin ligands ICAM-1 and iC3b
but does not impact on dendritic cell 3D migration speed in
response to chemokine stimulation. MRTF-A and SRF have
been shown to activate gene expression of proteins associated
with focal adhesions in fibroblasts and are associated with
migration and invasion in a cancer cell line (16). In hematopoietic
stem cells SRF regulates adhesion and integrin expression
(35). In neutrophils, SRF has been shown to be essential
for adhesion and extravasation (36), whilst in macrophages
SRF independent gene targets of MRTF-A were predicted to
be focal adhesion associated (40). Deletion of MRTF-A in
neutrophils leads to impaired 2D migration associated with
altered adhesion (14). Therefore, our results together with
published studies confirm that MRTFA/SRF transcription factors
play an important role in regulating the adhesive phenotype of
myeloid immune cells.
We have linked the reduced adhesion to reduced traction
forces upon MRTF-A inhibition. This result could be interpreted
as that the integrin/kindlin-3 interaction is necessary for overall
generation of traction forces, because the integrin/kindlin
interaction is required for optimal integrin function. Traction
forces are generated by interaction of the (actin-) cytoskeleton
with myosin. Both actin and myosin are MRTF-A/SRF target
genes. We thus hypothesize that reduced adhesion following
MRTF-A inhibition in dendritic cells may be due to altered
cytoskeletal organization which ultimately renders the dendritic
cells less able to generate integrin-mediated traction forces.
An alternative explanation would be that kindlin-3 and talin
interaction with the β2-integrin is regulated by SRF, as was
shown in SRF−/− neutrophils (36). This alternative would extend
the regulatory feedback loop between β2-integrin/kindlin-3, F-
actin and MRTF-A back to the integrin regulators kindlin-3
and talin.
Interestingly, like β2-integrin deficiency and kindlin-3
deficiency, which lead to LAD-syndromes in man, MRTF-
A deficiency in man has recently been shown to lead to
immunodeficiency with prominent susceptibility to bacterial
infections (14). Patient neutrophil and lymphocyte functions,
such as migration, was impaired, and patient dendritic cells
displayed impaired spreading and podosome formation (14),
as we have previously reported in TTT/AAA-β2-integrin KI
dendritic cells (41). The similarities of symptoms in human
MRTF-A deficiency and β2-integrin deficiency, together with
the results presented here, indicate that some of the functions of
integrins and kindlin-3 in immune cells, which are impaired in
LAD patients may involve regulation of transcription through
the MRTF-A/SRF pathway. We hypothesize that abnormal
expression of actin cytoskeleton genes due to specific defects
in the MRTF-A/SRF pathway in LAD cells may contribute to
immune defects (e.g., defects in myeloid cell adhesion, migration,
phagocytosis, etc) in LAD diseases.
MRTF-A has previously been shown to regulate the
development of specific adipocyte subpopulations (42) and
is essential for thymocyte development (39). SRF deletion
in hematopoetic stem cells led to accumulation of CD11b
positive cells and thus an increase in macrophage like cells
(35). Interestingly, cell adhesion, which maintains active MRTF-
A/SRF signaling, has recently been shown to be essential to
prevent progenitor cells from switching to the adipocyte lineage
during cardiomyocyte differentiation (43). Mechanistical data
illustrating the role of SRF and MRTF-A in the regulation of
cellular identity has been gathered from neural and liver cells. In
these cells, induced MRTF-A nuclear accumulation resulted in
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FIGURE 6 | Traction force generation in dendritic cells is regulated by the β2-integrin/MRTF-A/SRF pathway. (A) Heatmaps depicting traction force generated by WT
and TTT/AAA KI dendritic cells and (C) non treated WT and MRTF-A inhibited WT dendritic cells. (B) Scatter plots of analyzed WT and KI dendritic cells and (D) non
treated WT and MRTF-A inhibited WT dendritic cell traction forces (Pa) are shown. Three experiments were performed, 25 cells were measured each time and a total
of 75 cells analyzed. (E) Heatmaps depicting traction force generated by an example MRTF-A+/+ and −/− dendritic cells. (F) Scatter plots of analyzed MRTF-A+/+
and −/− dendritic cells N = 4. *p < 0.05, ***p < 0.005.
downregulation of cell-type specific genes, changes in epigenetic
status of regulator elements as well as chromatin organization
(44). It is interesting to note that in dendritic cells, our gene
expression profiling data now show that MRTF-A regulates genes
that are associated with the cell cycle and with lipid metabolism,
indicating new roles of this pathway in metabolism and cell
proliferation/differentiation in immune cells, topics for further
studies in the future.
In summary, our results indicate that the β2-integrin-
regulated MRTF-A/SRF pathway is a key regulatory element in
dendritic cells that regulates gene expression associated with
cell cycle, lipid metabolism and the cytoskeleton. β2-integrins
regulate MRTF-A/SRF signaling and expression of cytoskeletal
genes, and enables the adhesive dendritic cell phenotype and
integrin-mediated traction force generation. We thus propose
that the β2-integrin-regulated MRTF-A/SRF pathway may
function as a roadblock that needs to be overcome in dendritic
cells for them to initiate the phenotypic switch from an adhesive
to a mature, migratory phenotype.
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